Skip to main content (Press Enter).
Member Login
Skip auxiliary navigation (Press Enter).
National Alliance Website
MEMBER CONNECT
Skip main navigation (Press Enter).
Toggle navigation
Search Options
Home
Communities
All Communities
My Communities
Directory
Coalition Member Directory
All Coalition Members
Events
Upcoming Events
Browse
Discussion Posts
Library Entries
All Initiatives Related Resources
Participate
Help/FAQs
Public Resources
Back to Library
Achieving Value Through Health: Latest Evidence on Pharmacogenomics
0
Recommend
3 days ago
National Alliance of Healthcare Purchaser Coalitions
Pharmacogenomics (PGx) is a core element of precision medicine,
reducing the likelihood of adverse drug reactions and optimizing therapeutic efficacy.
We will review and discuss the latest evidence on improving outcomes and affordability for certain PGx treatments in areas such as mental health and cancer.
SUGGESTED PRE-READING:
New Research Finds Precision Medicine has reached a Global Tipping Point for Adoption
Maturing Pharmacogenomic Factors Deliver Improvements and Cost Efficiencies"
Attachment(s)
Achieving Value through Health Latest Evidence of Pharmac...pdf
8.51 MB
1 version
Uploaded - 01-25-2023
Download
Download Document
Please accept the terms of the copyright associated with this attachment before downloading it. Click the link below to read the terms.
Accept
Video
9cbd6c8c-8a6c-0a4a-ac4d-e170e8a39a26_file
01:00:27
Related Entries and Links
No Related Resource entered.
National Alliance of Healthcare Purchaser Coalitions
1015 18th Street, NW, Suite 705
Washington, DC 20036
(202) 775-9300 (phone)
(202) 775-1569 (fax)
Contact Us
Site Terms and Conditions
Copyright 2022. All rights reserved.
Powered by Higher Logic